Psychopharmacology and Psychiatry Updates

Podcast autorstwa Psychopharmacology Institute

Kategorie:

213 Odcinki

  1. Acute Agitation and Dexmedetomidine: A Novel Treatment Approach

    Opublikowany: 30.08.2023
  2. The Prevalence and Risks of RBD

    Opublikowany: 25.08.2023
  3. ADHD Medication and Their Role in Anxiety and Depression

    Opublikowany: 20.08.2023
  4. In the Realm of Sleep: RBD Diagnosis Explained

    Opublikowany: 15.08.2023
  5. NAC in Schizophrenia: Pie in the Sky or Groundbreaking Solution?

    Opublikowany: 10.08.2023
  6. Child Psychiatry: NAC and SAMe

    Opublikowany: 5.08.2023
  7. Youth Psychotropic Prescription Trends: Pandemic Influence

    Opublikowany: 31.07.2023
  8. Nature's Remedies in Youth: St. John's Wort and Valerian

    Opublikowany: 26.07.2023
  9. Exploring Serotonergic Antidepressants for PMDD

    Opublikowany: 21.07.2023
  10. Exploring Omega-3's Role in Child Psychiatry

    Opublikowany: 16.07.2023
  11. ADHD Meds for Preschoolers: Lisdexamfetamine

    Opublikowany: 11.07.2023
  12. Using Ginkgo Biloba in Children

    Opublikowany: 6.07.2023
  13. Examining COVID's Lasting Effects in Psychiatry

    Opublikowany: 1.07.2023
  14. Beyond SSRIs: Antipsychotic Augmentation in OCD

    Opublikowany: 26.06.2023
  15. Overcoming Barriers to Metabolic Monitoring in Youth Treated With SGAs

    Opublikowany: 21.06.2023
  16. Exploring Outcomes and Strategies in OCD Treatment After the First Trial

    Opublikowany: 16.06.2023
  17. Diving Into the APA Annual Meeting: Highlights and Insights!

    Opublikowany: 11.06.2023
  18. Exploring the Intriguing World of Microdosing Psilocybin

    Opublikowany: 6.06.2023
  19. SSRIs for OCD: A Closer Look at First-Line Treatment

    Opublikowany: 1.06.2023
  20. Exploring Nonstimulant Treatments for ADHD

    Opublikowany: 27.05.2023

4 / 11

Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.

Visit the podcast's native language site